腎除神経デバイス市場：技術、製品、疾患用途、エンドユーザー別-2024-2030年の世界予測

腎除神経デバイス市場規模は、2023年に2億3,629万米ドルと推定され、2024年には2億6,644万米ドルに達し、CAGR 13.68%で2030年には5億7,985万米ドルに達すると予測されます。

腎除神経デバイスは、従来の薬物療法では十分な効果が得られない薬剤抵抗性高血圧や高血圧に悩む患者に低侵襲治療を提供する医療機器です。これらのデバイスは、血圧の調節に重要な役割を果たし、高血圧の発症に寄与する腎動脈周囲の過剰な交感神経を標的とすることで、代替的な解決策を提供します。ライフスタイルの変化による世界人口の抵抗性高血圧の有病率の増加、従来の薬物療法に対する腎除神経手技の利点に関する意識の高まり、高齢者人口の増加が腎除神経デバイス市場の成長を促進しています。しかし、腎除神経デバイスの高額なコスト、関連する処置、いくつかの厳しい規制の枠組みが市場成長の妨げになる可能性があります。機器設計や手技の技術的進歩により、腎除神経治療の有効性と安全性プロファイルが向上しており、有利な市場機会を生み出すと期待されています。

技術：超音波ベースの腎除神経技術の高い採用率

マイクロインフュージョンに基づく腎除神経では、少量の降圧剤を腎動脈周囲の腔に直接投与します。この標的アプローチは全身的な副作用を最小限に抑え、薬効を向上させる。薬理学的アブレーションでは、アルコールやグアネチジンなどの神経毒性薬剤を用いて、過剰に活動する腎神経を化学的に破壊します。この手技は、高周波や超音波を用いたアプローチが解剖学的に複雑であったり禁忌であったりするために実行不可能な場合に好まれます。高周波を用いた腎除神経術では、制御された電気エネルギーを印加して、標的とする腎神経を破壊します。この方法は、その正確さ、安全性、血圧降下の有効性から好まれています。超音波ベースの腎除神経は、高周波音波を使用して局所的な熱を発生させ、過活動状態の腎神経を破壊します。この非侵襲的な方法は、他の方法に禁忌や過敏症のある患者にとって魅力的です。

製品多電極カテーテルは手技時間が短いため、かなり使用されています。

カテーテルは、高血圧の原因となる神経を切除または修正するために高周波エネルギーを供給する腎除神経手技で使用される主要な機器です。カテーテルは主に、低侵襲性と特定の神経をターゲットとする精度のために使用されます。多電極カテーテルは先端に複数の電極があり、複数の神経部位を同時に焼灼できるため、手技時間が短縮され、効果が高まる可能性があります。神経修飾剤とは、腎除神経デバイスとともに作用して手技の結果を向上させる医薬品です。これらの薬剤は患者全体の反応を改善したり、手技から生じる可能性のある合併症を最小限に抑えたりします。RF（高周波）発生器は、神経を切除するカテーテルに制御されたエネルギーを供給するために、腎除神経手技で使用される必須の装置です。単電極カテーテルは、先端に1つの電極があり、神経部位を順次焼灼するために使用されます。これらのカテーテルは特定の神経をターゲットとする精度が高いが、多電極カテーテルに比べ手技に時間がかかることがあります。

疾患への応用：高血圧治療における腎除神経デバイスの使用拡大

腎除神経デバイスは、高血圧や腎症を患う糖尿病患者に対する効果的な治療法として登場しました。腎除神経デバイスは、糖尿病合併症を悪化させる交感神経の過活動を抑制します。心不全患者では交感神経の活動が亢進し、血圧上昇や体液過負荷を引き起こし、腎障害を進行させる要因となっています。腎除神経療法は、このような患者の交感神経亢進を効果的に抑制し、心機能と全体的なQOLを改善することができます。高血圧症では、腎除神経は腎交感神経を障害し、血圧調節への影響を減少させることで血圧を下げるのに役立ちます。腎除神経デバイスは、高血圧や糖尿病合併症に苦しむことの多い慢性腎臓病（CKD）患者に対する潜在的な治療オプションとして検討されています。交感神経系を調節する本治療法は、CKDの進行を遅らせ、腎機能障害に伴う症状を緩和するのに役立つ可能性があります。

エンドユーザー：外来医療センターは、低侵襲で費用対効果の高いソリューションとして腎除神経デバイスを優先的に使用

外来診療センター（ACC）は、腎臓関連疾患の診断や治療を含む様々な医療サービスを提供する外来施設で、高血圧患者の管理に腎除神経デバイスを提供しています。ACCは、患者の安全性と快適性を確保すると同時に、業務効率を最大化するために、低侵襲で費用対効果の高いソリューションを好んでいます。診断センターと病院は、早期発見と介入を通じて高血圧を管理する上で極めて重要です。コントロールされていない高血圧や薬剤耐性の症例が世界的に増加しているため、これらの施設では、患者の転帰を最適化するための高度な腎除神経デバイスが必要とされています。病院は、腎除神経デバイスを選択する際、使いやすさ、既存の機器への適応性、強固な臨床データサポートを優先します。研究機関や学術センターは高血圧管理の最前線にあり、腎除神経のための新しい治療法や機器を開発しています。これらの組織は、この分野における将来の進歩を支える強力な臨床エビデンスを備えた最先端技術に注力しています。

地域別の洞察

南北アメリカは、人口の間で高血圧の有病率が高く、新規治療法の研究に多額の投資を行っているため、市場情勢は重要です。テクノロジーの進歩と医療従事者の革新的な治療法に対する意識の高まりが、こうした機器の需要を促進しています。EUは、腎除神経療法に対する意識の高まりと、各国における有利な償還政策により、市場成長の大きな可能性を示しています。高血圧の予防と管理に関する協力的な取り組みが、この領域での研究開発イニシアチブを加速させています。MEA地域は、ライフスタイルの変化や都市化と相まって高血圧の罹患率が上昇しているため、腎除神経デバイスにとって有望な市場です。APAC地域では、高血圧研究に対する政府の資金援助やイニシアチブの結果、臨床試験や特許出願の数が増加しています。強固なヘルスケアインフラ、技術進歩への強い関心、高血圧管理に対する意識の高まり、医療施設の改善が、同地域の腎除神経デバイス市場成長に寄与しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは腎除神経デバイス市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、腎除神経デバイス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.腎除神経デバイス市場の市場規模および予測は？

2.腎除神経デバイス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.腎除神経デバイス市場の技術動向と規制枠組みは？

4.腎除神経デバイス市場における主要ベンダーの市場シェアは？

5.腎除神経デバイス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化に伴い慢性腎不全の罹患率が上昇
    • 低侵襲手術の採用と傾向の高まり
  • 抑制要因
    • 腎除神経デバイスに関連する高コスト
  • 機会
    • 腎除神経デバイスにおける技術の進歩と改善
    • 腎神経除去の臨床ガイドラインの継続的な出版と臨床評価研究の増加
  • 課題
    • 製品承認に関する厳しい政府規制と経験豊富なヘルスケア専門家の不足
• 市場セグメンテーション分析
  • 技術：超音波による腎神経除去技術の採用率が高い
  • 製品：処置時間の短縮のため、多電極カテーテルの使用が増加
  • 疾患応用：高血圧治療における腎除神経デバイスの使用増加
  • エンドユーザー：外来診療センターは、低侵襲で費用対効果の高いソリューションとして腎除神経デバイスを優先します。
• 市場動向分析
  • 南北アメリカでは、医療機器メーカーの存在と医療専門家の支持の高まりにより、腎除神経デバイスに対する政府の承認が好意的に得られています。
  • 高血圧の診断と治療の改善に向けた政府支援の拡大と、アジア太平洋地域における腎除神経デバイスの臨床試験からの肯定的な結果の増加
  • EMEA地域全体における腎除神経デバイスを支援する政府の取り組みと承認手続き
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 腎除神経デバイス市場：技術別

• マイクロインフュージョンベース
• 薬理学的アブレーション
• 無線周波数ベース
• 超音波ベース

第7章 腎除神経デバイス市場：製品別

• カテーテル
• 神経修飾剤
• RFジェネレータ

第8章 腎除神経デバイス市場疾患別用途

• 糖尿病
• 心不全
• 高血圧
• 腎不全

第9章 腎除神経デバイス市場：エンドユーザー別

• 外来診療センター
• 診断センターと病院
• 調査と学術

第10章 南北アメリカの腎除神経デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の腎除神経デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの腎除神経デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • レコーメディカルと大塚メディカルデバイス、高血圧治療用の初のFDA承認腎神経除去システムを発表
  • FDAがVerve MedicalのIDE腎盂神経除去試験を承認
  • 韓国のスタートアップ企業カロス、高血圧治療のための腎神経除去装置の開発で350万米ドルの助成金を獲得
  • 治療抵抗性高血圧症に対する超音波アブレーションを用いた腎神経除去術の早期効果評価がドイツで実施中
  • Andera Partnersが高血圧治療のための有望なデバイスを開発する医療技術企業SoniVieに投資
  • フランスのメドトロニック社製腎除神経カテーテルSYMPLICITY SPYRALの移行カバー
  • 上海ゴールデンリーフメディカルテック株式会社がシリーズCラウンドで数百万人民元を確保
  • SPYRAL HTN-ON MED試験は、他のSPYRAL HTN腎神経除去試験と一致する有意義な臨床的利点を実証しました
  • ソニヴィー、腎動脈神経遮断TIVUS技術を用いた高血圧治療のパイロットスタディでFDAからIDE承認を取得
  • Ablative Solutions、シリーズD資金調達ラウンドで9,140万米ドルを調達
  • Clinical AcceleratorがVerve Medicalと提携し、治療抵抗性高血圧症の早期ヒト実現可能性研究を実施することを発表

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. RENAL DENERVATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. RENAL DENERVATION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
• FIGURE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 6. RENAL DENERVATION DEVICES MARKET DYNAMICS
• FIGURE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 15. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 17. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 19. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 23. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RENAL DENERVATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2023 (USD THOUSAND)
• TABLE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2024-2030 (USD THOUSAND)
• TABLE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 6. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 15. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 16. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 17. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 18. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 19. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 20. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 21. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 22. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 23. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 24. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 25. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 26. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 27. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 28. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 29. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 30. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 31. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 32. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 33. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 34. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 35. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 36. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 37. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 38. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 39. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 40. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 41. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 42. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 43. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 44. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 45. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 46. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 47. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2023 (USD THOUSAND)
• TABLE 48. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2024-2030 (USD THOUSAND)
• TABLE 49. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 50. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 51. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 52. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 53. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 54. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 55. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 56. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 57. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 58. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 59. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
• TABLE 60. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
• TABLE 61. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 62. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 63. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 64. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 65. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 66. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 67. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 68. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 69. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 70. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 71. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 72. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 73. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 74. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 75. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 76. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 77. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 78. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 79. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 80. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 81. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 82. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 83. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 84. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 85. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 86. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 87. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 88. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 89. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 90. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 91. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 92. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 93. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 94. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 95. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 96. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 97. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 98. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 99. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 100. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 101. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 102. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 103. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 104. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 105. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 106. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 107. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 108. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 109. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 110. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 111. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
• TABLE 112. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
• TABLE 113. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 114. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 115. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 116. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 117. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 118. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 119. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 120. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 121. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 122. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 123. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
• TABLE 124. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
• TABLE 125. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 126. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 127. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 128. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 129. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 130. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 131. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 132. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 133. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 134. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 135. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 136. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 137. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 138. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 139. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 140. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 141. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 142. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 143. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 144. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 145. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 146. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 147. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 148. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 149. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 150. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 151. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 152. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 153. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 154. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 155. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 156. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 157. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 158. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 159. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 160. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 161. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 162. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 163. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 164. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 165. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 166. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 167. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 168. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 169. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 170. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 171. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 172. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 173. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 174. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 175. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 176. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 177. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 178. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 179. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 180. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 181. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 182. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 183. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 184. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 185. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 186. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 187. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 188. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 189. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 190. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 191. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 192. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 193. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 194. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 195. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 196. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 197. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 198. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 199. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 200. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 201. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 202. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 203. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 204. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 205. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 206. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 207. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 208. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 209. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 210. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 211. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 212. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 213. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 214. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 215. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 216. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 217. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 218. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 219. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 220. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 221. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 222. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 223. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 224. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 225. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 226. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 227. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 228. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 229. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 230. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 231. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 232. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 233. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 234. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 235. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 236. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 237. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 238. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 239. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 240. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 241. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 242. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 243. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 244. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
• TABLE 257. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 258. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 259. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 260. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 261. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 262. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 263. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 264. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 265. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 266. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 267. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 268. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 269. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 270. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 271. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 272. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 273. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 274. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 275. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 276. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 277. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 278. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 279. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 280. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 281. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 282. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 283. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 284. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 285. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 286. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 287. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 288. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 289. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 290. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 291. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 292. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 293. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 294. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 295. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 296. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 297. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 298. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 299. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 300. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 301. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 302. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 303. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 304. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 305. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 306. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 307. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 308. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 309. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 310. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 311. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 312. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 313. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 314. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 315. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
• TABLE 316. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
• TABLE 317. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
• TABLE 318. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
• TABLE 319. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
• TABLE 320. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
• TABLE 321. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
• TABLE 322. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
• TABLE 323. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
• TABLE 324. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
• TABLE 325. ITALY RENAL DENERVATION DEVICES MARKE

[192 Pages Report] The Renal Denervation Devices Market size was estimated at USD 236.29 million in 2023 and expected to reach USD 266.44 million in 2024, at a CAGR 13.68% to reach USD 579.85 million by 2030.

Renal denervation devices are medical tools that provide minimally invasive therapy for patients suffering from drug-resistant hypertension or high blood pressure that do not respond adequately to conventional pharmacological therapies. These devices offer an alternative solution by targeting the overactive sympathetic nerves surrounding the renal arteries, which play a crucial role in regulating blood pressure and contribute to the development of hypertension. The increasing prevalence of resistant hypertension among the global population due to lifestyle changes, rising awareness about the benefits of renal denervation procedures over conventional drug therapies, and the growing geriatric population are driving the renal denervation devices market growth. However, the high cost of renal denervation devices, associated procedures, and several stringent regulatory frameworks may hamper market growth. Technological advancements in device design and procedural techniques have improved efficacy and safety profiles for renal denervation treatments, which is expected to create a lucrative market opportunity.

Technology: High adoption of ultrasound-based renal denervation technology

Micro-infusion-based renal denervation involves delivering small doses of anti-hypertensive drugs directly into the periarterial space surrounding the renal arteries. This targeted approach minimizes systemic side effects and improves drug efficacy. Pharmacologic ablation involves chemically destroying overactive renal nerves using neurotoxic agents such as alcohol or guanethidine. This technique is preferred when radiofrequency or ultrasound-based approaches are not feasible due to anatomical complexities or contraindications. Radiofrequency-based renal denervation involves applying controlled electrical energy to destroy targeted renal nerves. This method is preferred for its precision, safety, and effectiveness in reducing blood pressure. Ultrasound-based renal denervation uses high-frequency sound waves to generate localized heat that disrupts overactive renal nerves. This non-invasive technique makes it attractive for patients with contraindications or sensitivities to other methods.

Product: Significant use of multi-electrode catheters for their shorter-time of procedures

Catheters are the primary device used in renal denervation procedures to deliver radiofrequency energy to ablate or modify nerves responsible for hypertension. They are primarily used for their minimally invasive nature and precision in targeting specific nerves. Multi-electrode catheters have multiple electrodes on the tip that enable simultaneous ablation of multiple nerve sites, reducing procedure time and potentially increasing efficacy. Nerve-modifying agents are pharmaceuticals that work alongside renal denervation devices to enhance procedural outcomes. These agents may improve overall patient response or minimize potential complications arising from the procedure. An RF (Radiofrequency) generator is an essential device used in renal denervation procedures for providing controlled energy to catheters to ablate nerves. Single electrode catheters feature a single electrode at the tip and are used for sequential ablation of nerve sites. These catheters offer greater precision in targeting specific nerves but may require longer procedures than multi-electrode variants.

Disease Application: Proliferating use of renal denervation devices for treating hypertension

Renal denervation devices have emerged as an effective treatment for diabetic patients suffering from hypertension and nephropathy. These devices modulate the overactive sympathetic nervous system responsible for worsening diabetic complications. Heart failure patients experience high sympathetic activity, leading to increased blood pressure and fluid overload factors contributing to progressive kidney damage. Renal denervation therapy can effectively reduce sympathetic hyperactivity in these patients, improving cardiac function and overall quality of life. In hypertension, renal denervation helps lower blood pressure by disrupting the renal sympathetic nerves, reducing their influence on blood pressure regulation. Renal denervation devices are being explored as a potential treatment option for chronic kidney disease (CKD) patients who often suffer from hypertension and diabetic complications. The therapy's ability to modulate the sympathetic nervous system may help slow CKD progression and alleviate symptoms associated with kidney dysfunction.

End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution

Ambulatory care centers (ACCs) are outpatient facilities that provide various medical services, including diagnosis and treatment for kidney-related diseases, and offer renal denervation devices to manage patients with hypertension. ACCs prefer minimally invasive and cost-effective solutions to ensure patient safety and comfort while maximizing operational efficiency. Diagnostic centers and hospitals are crucial in managing hypertension through early detection and intervention. With a growing global prevalence of uncontrolled hypertension and drug-resistant cases, these institutions require advanced renal denervation devices for optimal patient outcomes. Hospitals prioritize ease of use, adaptability with existing equipment, and robust clinical data support when selecting renal denervation devices. Research institutions and academic centers are at the forefront of hypertension management, developing novel therapies and devices for renal denervation. These organizations focus on cutting-edge technology with strong clinical evidence to support future advancements in the field.

Regional Insights

The Americas has a significant landscape in the renal denervation devices market due to a high prevalence of hypertension among its population and substantial investments in research for novel therapies. Advancements in technology and growing awareness about innovative treatment options amongst healthcare professionals have fueled demand for these devices. The EU shows significant potential for market growth owing to increased awareness about renal denervation therapy and favorable reimbursement policies across countries. Collaborative efforts on hypertension prevention and control have accelerated R&D initiatives in this domain. The MEA region holds promising opportunities for renal denervation devices due to a rising incidence of hypertension coupled with lifestyle changes and urbanization. In the APAC region, government funding and initiatives for hypertension research resulted in a growing number of clinical trials and patent filings. Robust healthcare infrastructure, a strong focus on technological advancements, increased awareness about hypertension management, and improved healthcare facilities have contributed to the region's renal denervation devices market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Renal Denervation Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Renal Denervation Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., AngioDynamics, Inc., Aria CV, Inc., AtriCure, Inc., Bio-Heart, Boston Scientific Corporation, Cardinal Health, Inc., Kalos Medical, Medtronic PLC, Mercator MedSystems, Inc., Otsuka Holdings Co., Ltd., Shanghai Meiliweiye Medical Technology Co., Ltd., SoniVie, Symap Medical, Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Technology
  • Micro-Infusion-Based
  • Pharmacologic Ablation
  • Radiofrequency-Based
  • Ultrasound-Based

• Products
  • Catheters
    • Multi Electrode Catheter
    • Single Electrode Catheter

• Nerve Modifying Agents
• RF Generator

• Disease Application
  • Diabetes
  • Heart Failure
  • Hypertension
  • Renal Failure

• End-User
  • Ambulatory Care Centers
  • Diagnostic Centers & Hospitals
  • Research & Academia

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Renal Denervation Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Renal Denervation Devices Market?

3. What are the technology trends and regulatory frameworks in the Renal Denervation Devices Market?

4. What is the market share of the leading vendors in the Renal Denervation Devices Market?

5. Which modes and strategic moves are suitable for entering the Renal Denervation Devices Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of congestive chronic renal failure with aging population
    • 5.1.1.2. Growing adoption and inclination towards minimally invasive surgical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with renal denervation devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and improvements in renal denervation devices
    • 5.1.3.2. Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
  • 5.1.4. Challenges
    • 5.1.4.1. Strict government regulations for product approval coupled with lack of experienced healthcare professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: High adoption of ultrasound-based renal denervation technology
  • 5.2.2. Product: Significant use of multi-electrode catheters for their shorter-time of procedures
  • 5.2.3. Disease Application: Proliferating use of renal denervation devices for treating hypertension
  • 5.2.4. End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution
• 5.3. Market Trend Analysis
  • 5.3.1. Favorable government approvals for renal denervation devices in the Americas backed by the presence of well-established medical device companies and rising medical professional acceptance
  • 5.3.2. Expanding government support to improve diagnosis and treatment of hypertension coupled with increasing positive results from clinical trials of renal denervation devices in the APAC region
  • 5.3.3. Supportive government initiatives and approval procedures for renal denervation devices across the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Renal Denervation Devices Market, by Technology

• 6.1. Introduction
• 6.2. Micro-Infusion-Based
• 6.3. Pharmacologic Ablation
• 6.4. Radiofrequency-Based
• 6.5. Ultrasound-Based

7. Renal Denervation Devices Market, by Products

• 7.1. Introduction
• 7.2. Catheters
• 7.3. Nerve Modifying Agents
• 7.4. RF Generator

8. Renal Denervation Devices Market, by Disease Application

• 8.1. Introduction
• 8.2. Diabetes
• 8.3. Heart Failure
• 8.4. Hypertension
• 8.5. Renal Failure

9. Renal Denervation Devices Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Care Centers
• 9.3. Diagnostic Centers & Hospitals
• 9.4. Research & Academia

10. Americas Renal Denervation Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Renal Denervation Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Renal Denervation Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
  • 13.3.2. FDA Approves Verve Medical's IDE Renal Pelvic Denervation Trial
  • 13.3.3. Korean Startup Kalos Gets USD 3.5 Million Grant to Develop Renal Denervation Device for hypertension Treatment
  • 13.3.4. Renal Denervation Using Ultrasound Ablation in Treatment-Resistant Hypertension is Being Evaluated for Early Benefit Assessment in Germany
  • 13.3.5. Andera Partners Invests in SoniVie, a Medtech Company Developing a Promising Device for the Treatment of Hypertension
  • 13.3.6. Transitional Coverage for Renal Denervation Catheter SYMPLICITY SPYRAL from Medtronic in France
  • 13.3.7. Shanghai Golden Leaf Med Tec Co., Ltd Secures Hundreds of Mns of CNY in Series C Round
  • 13.3.8. SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with other SPYRAL HTN Renal Denervation Trials
  • 13.3.9. SoniVie Receives IDE Approval from FDA for its Pilot Study to Treat Hypertension with its Renal Artery Denervation TIVUS Technology
  • 13.3.10. Ablative Solutions Raises USD 91.4 Million in Series D Financing Round
  • 13.3.11. Clinical Accelerator Announces Collaboration with Verve Medical to Conduct an Early Human Feasibility Study for Treatment-Resistant Hypertension

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio